Breaking News Instant updates and real-time market news.

AAPL

Apple

$266.41

4.6 (1.76%)

, BAC

Bank of America

$33.47

0.3 (0.90%)

08:55
11/26/19
11/26
08:55
11/26/19
08:55

Notable open interest changes for November 26th

Monday's total option volume of 18.6 million contracts resulted in net open interest growth of 3.30 million calls and 3.13 million puts. Apple (AAPL), Bank of America (BAC), Tesla (TSLA) and Macy's (M) saw the greatest growth. Top five new positions opened include 93k Teva (TEVA) Mar-20 12 puts, 50k Bank of America (BAC) 12/27 weekly 32 puts, 25k AT&T (T) Mar-20 39 calls, 23k Macy's (M) 11/29 weekly 16.5 calls and 21k Macy's (M) Dec-19 13.5 puts.

AAPL

Apple

$266.41

4.6 (1.76%)

BAC

Bank of America

$33.47

0.3 (0.90%)

TSLA

Tesla

$336.35

3.44 (1.03%)

M

Macy's

$15.56

0.13 (0.84%)

  • 07

    Jan

  • 15

    Jan

  • 26

    Feb

AAPL Apple
$266.41

4.6 (1.76%)

11/19/19
FBCO
11/19/19
NO CHANGE
Target $221
FBCO
Neutral
Apple's iPhone unit trends remain 'solid,' says Credit Suisse
Credit Suisse analyst Matthew Cabral tells investors in a research note that nearly two months into the iPhone 11 cycle, data points continue to suggest a meaningful improvement in units y/y. Government data suggests iPhone units are up 6% y/y in China over September and October combined, with Cabal adding that his firm's tracking data suggesting the iPhone has yet to hit full supply/demand balance eight weeks post-launch. While Cabral says he is "on board" with the idea that the shift toward Services deserves a higher multiple over time, he "struggles" with continued P/E expansion seemingly led by firming iPhone data points rather than Services-driven upside. The analyst keeps a Neutral rating and $221 price target on Apple shares.
11/18/19
SOCG
11/18/19
NO CHANGE
Target $200
SOCG
Sell
Societe Generale sees big downside in Netflix shares with 'uniqueness' eroding
A "wider competitive set" has started to dilute Netflix's (NFLX) perceived "uniqueness" and will probably restrain its pricing power in the short term, Societe Generale analyst Christophe Cherblanc tells investors in a research note. The low price points set by Disney+ (DIS) at $6.99 per month and Apple TV+ (AAPL) at $4.99 per month will likely make Netflix more cautious exercising its pricing power, Cherblanc contends. Further, he believes the company's 2019 price increases have had a slightly higher than expected impact on U.S. churn. The analyst keeps a Sell rating on Netflix with a $200 price target. The streaming service closed Friday up $5.41 to $295.03. Despite the recent pullback, the shares still have "significant downside" risk, Cherblanc contends. Nonetheless, the analyst thinks Netflix will retain a dominant position in a "rapidly expanding" over-the-top market and deliver steady margin expansion.
11/15/19
JPMS
11/15/19
NO CHANGE
Target $290
JPMS
Overweight
JPMorgan ups Apple target to $290 on 'underappreciated' advertising opportunity
JPMorgan analyst Samik Chatterjee raised his price target for Apple to $290 from $280 and reiterates an Overweight rating on the shares. Following the stock's strong run, investor attention is increasingly focusing on identifying new avenues of Services revenue growth beyond the current ventures, such as Apple Music, Apple Pay, Apple Arcade, and its latest, Apple TV+, "which are still very much in early innings," Chatterjee tells investors in a research note. However, he believes "hidden in plain sight and underappreciated by most" is Apple's advertising opportunity. The analyst highlights the "secular migration" of advertising dollars to mobile platforms and Apple's large installed base of close to 1B iPhone users. Chatterjee estimates that if Apple were willing to accelerate monetization of advertising through an expansion of its current efforts with Apple Search Ads as well as adopting new strategies around Apple TV, it could expand advertising revenues 33% per annum to $11B in fiscal 2020 from an estimated ~$2B currently. Piper Jaffray this morning also raised its price target on Apple to $290.
11/19/19
WEDB
11/19/19
NO CHANGE
Target $325
WEDB
Outperform
China the 'linchpin' of success on Apple iPhone supply chain, says Wedbush
Wedbush analyst Daniel Ives tells investors in a research note that President Trump is expected to visit Apple's tech manufacturing facility in Austin, Texas along with CEO Tim Cook in what he calls a key strategic visit for the company. While Ives says he sees more AI and hardware manufacturing coming out of the U.S., India, and potentially Vietnam down the road, for the foreseeable future China remains the "linchpin" of success on the iPhone supply chain with Cook needing to "play nice in the sandbox" both in the U.S. as well as in China to make sure no new roadblocks appear that could derail this potential "5G super cycle" heading into 2020. He keeps an Outperform rating and $325 price target on Apple shares.
BAC Bank of America
$33.47

0.3 (0.90%)

10/22/19
10/22/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Discovery (DISCA) upgraded to Outperform from In-Line at Imperial Capital with analyst David Miller sayign amidst changes in the Media sector, and against "various levels of turmoil" within many of the company's peers, Discovery has emerged "as one of the cleaner stories in the sector." 2. Dropbox (DBX) upgraded to Buy from Neutral at Nomura Instinet with analyst Christopher Eberle saying the company is nearing an inflection in revenue after six quarters of deceleration as a public company and its current valuation is attractive. 3. Workday (WDAY) and Anaplan (PLAN) upgraded to Outperform from In Line at Evercore ISI. 4. Owens Corning (OC) upgraded to Buy from Neutral at Buckingham with analyst Megan McGrath saying the company's installation business should benefit from recent improved volumes in residential U.S. construction and potentially improved price stability. 5. Bank of America (BAC) upgraded to Overweight from Neutral at Atlantic Equities. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/29/19
SOCG
10/29/19
DOWNGRADE
SOCG
Sell
Bank of America downgraded to Sell from Hold at Societe Generale
Societe Generale analyst Andrew Lim downgraded Bank of America to Sell from Hold.
10/28/19
10/28/19
UPGRADE

Buy
Bank of America upgraded to Buy from Hold at Odeon Capital
As previously reported, Odeon Capital analyst Dick Bove upgraded Bank of America to Buy from Hold. Bove called the stock "a good investment," noting Bank of America's growth from a company "struggling to maintain its existence" to a large, stable one, although not the growth vehicle it once was. The analyst sees a revenue growth rate of 3.3% per year from now to 2025, net income that could grow at 4.9%, and earnings per share that could grow at 6.5%. He believes the increased confidence in Bank of America stock is driven by the company's balance sheet strength and its decision to base future growth on "internally generated revenues and earnings." Bove believes as long as it can "maintain reasonable loan quality its future earnings and dividend growth lends itself to a relatively high level of predictability."
10/28/19
ODEN
10/28/19
UPGRADE
ODEN
Buy
Bank of America upgraded to Buy from Hold at Odeon Capital
Odeon Capital analyst Dick Bove upgraded Bank of America to Buy from Hold.
TSLA Tesla
$336.35

3.44 (1.03%)

11/26/19
CHRS
11/26/19
DOWNGRADE
Target $346
CHRS
Hold
Tesla downgraded to Hold from Buy at China Renaissance
China Renaissance analyst Carson Ng downgraded Tesla to Hold from Buy with an unchanged price target of $346. The shares closed Monday up $3.30 to $336.34. The analyst cites valuation for the downgrade with the shares up 49% since September. Further, he expects the special design of the new Cybertruck to draw "polarized responses" from both consumers and investors. While "strong preorders" of Cybertruck show Tesla's potential to expand its product portfolio, the recent share price appreciation has at least partly factored in the positives associated with upcoming Model Y launches and Shanghai production, Ng tells investors in a research note.
11/22/19
JMPS
11/22/19
NO CHANGE
JMPS
Ford, GM buyers unlikely to make switch to Cybertruck, says JMP Securities
JMP Securities analyst Joseph Osha maintained a Market Perform rating on Tesla (TSLA) following the company's Cybertruck announcement event. The analyst sees the styling of the vehicle being a "tough sell" for most pickup buyers, and said it may be an option for a Lincoln Navigator or a Range Rover buyer, but has "a lot of difficulty imagining most F150 buyers making the switch." Osha also questioned whether the Cybertruck could be a real volume product for Tesla, or if it will be repeatedly be delayed, like Tesla's semi project.
11/22/19
FBCO
11/22/19
NO CHANGE
Target $200
FBCO
Underperform
Ford, GM can 'breathe sigh of relief' after Tesla event, says Credit Suisse
After Tesla (TSLA) unveiled its Cybertruck on Thursday night, Credit Suisse analyst Dan Levy says he expects expects the electric pickup truck to be a lifestyle vehicle, but amid a highly radical design, it is unclear who the core buyer will be. Levy thinks the legacy OEMs like Ford (F) and GM (GM) can "breathe a sigh of relief," as he doesn't expect Cybertruck to encroach on large pickup share. The analyst keeps an Underperform rating and $200 price target on Tesla shares.
11/22/19
ADAM
11/22/19
NO CHANGE
Target $375
ADAM
Buy
Tesla pickup unveiled with impressive specifications, says Canaccord
Canaccord analyst Jed Dorsheimer attended the Tesla "cybertruck" unveiling and came away impresses with its futuristic styling and impressive specifications which he believes are unique and will resonate with consumers leading to solid demand. Dorsheimer reiterated his buy rating and $345 price target on Tesla shares.
M Macy's
$15.56

0.13 (0.84%)

11/22/19
DBAB
11/22/19
NO CHANGE
Target $18
DBAB
Hold
Macy's price target lowered to $18 from $22 at Deutsche Bank
Deutsche Bank analyst Paul Trussell lowered his price target for Macy's to $18 from $22 and keeps a Hold rating on the shares. The analyst remains cautious around the department stores and specialty retail following the Q3 earnings season.
11/14/19
GUGG
11/14/19
NO CHANGE
Target $66
GUGG
Buy
Guggenheim raises price targets on off-price retailers TJX, Ross Stores
Guggenheim analyst Robert Drbul said the off-price sector remains one of his favorites in U.S. retail and he believes the environment will be supportive this holiday and in 2020 based on the inventory imbalance he sees in the marketplace today, which should create a product/buying environment that supports continued revenue gains. He predicts a return to postive double digit percentage earnings growth in 2020 and raised his price target on TJX (TJX) shares to $66 from $60 and his price target for Ross Stores (ROST) to $125 from $120. He has Buy ratings on both stocks. Elsewhere in the group, he keeps Neutral ratings on Burlington Stores (BURL), Nordstrom (JWN) and Macy's (M).
11/21/19
BOFA
11/21/19
NO CHANGE
Target $12
BOFA
Underperform
Macy's price target lowered to $12 from $14 at BofA/Merrill
BofA Merrill Lynch analyst Lorraine Hutchinson noted that after a "disappointing" third quarter, Macy's cut its fiscal-year outlook, estimating that the company's guidance implies Q4 comp sales being down 1.5% to 3%. She previously worried that the company's second half outlook was too optimistic and now thinks it looks more achievable, but sees a shift in the risk to FY20, during which she believes it will be challenging for Macy's to return to profitable growth. Hutchinson reiterates an Underperform rating on Macy's shares and lowered her price target on the stock to $12 from $14.
11/20/19
FBCO
11/20/19
NO CHANGE
Target $48
FBCO
Neutral
Kohl's price target lowered to $48 from $51 at Credit Suisse
Credit Suisse analyst Michael Binetti lowered his price target for Kohl's (KSS) to $48 from $51 following the company's Q3 results, saying he thought Kohl's would fare better than weaker industry trends considering a meaningful number of new initiatives, and says he was "disappointed" in the company's Q3 SSS miss. Binetti tells investors in a research note to investors that he sees incremental risk for Macy's (M) and Nordstrom (JWN) this week, adding that he doesn't see much change to concerns that without an external catalyst, underlying industry trends in softlines categories remain lackluster.

TODAY'S FREE FLY STORIES

ATRC

AtriCure

$30.99

1.29 (4.34%)

04:55
12/07/19
12/07
04:55
12/07/19
04:55
Conference/Events
AtriCure management to meet with JPMorgan »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACAD

Acadia

$51.37

0.915 (1.81%)

, AMGN

Amgen

$233.74

0.3 (0.13%)

04:55
12/07/19
12/07
04:55
12/07/19
04:55
Conference/Events
Clinical Trials on Alzheimer's Disease to hold conference »

12th Clinical Trials on…

ACAD

Acadia

$51.37

0.915 (1.81%)

AMGN

Amgen

$233.74

0.3 (0.13%)

AZN

AstraZeneca

$47.68

0.06 (0.13%)

BIIB

Biogen

$300.27

0.98 (0.33%)

CLB

Core Laboratories

$46.19

1.94 (4.38%)

DNA

Bought by RHHBY

$0.00

(0.00%)

ESALY

Eisai

$0.00

(0.00%)

JNJ

Johnson & Johnson

$140.36

0.79 (0.57%)

LLY

Eli Lilly

$119.59

-0.175 (-0.15%)

MRK

Merck

$88.84

0.09 (0.10%)

NVS

Novartis

$92.08

0.42 (0.46%)

RHHBY

Roche

$0.00

(0.00%)

TAK

Takeda Pharmaceutical

$20.27

-0.16 (-0.78%)

VCNX

Vaccinex

$4.95

-0.05 (-1.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 07

    Dec

  • 09

    Dec

  • 09

    Dec

  • 09

    Dec

  • 10

    Dec

  • 10

    Dec

  • 10

    Dec

  • 11

    Dec

  • 16

    Dec

  • 17

    Dec

  • 21

    Jan

  • 24

    Jan

  • 24

    Jan

  • 30

    Jan

  • 05

    Feb

  • 14

    Mar

MGTA

Magenta Therapeutics

$13.29

0.3 (2.31%)

04:55
12/07/19
12/07
04:55
12/07/19
04:55
Conference/Events
Magenta Therapeutics to hold an investor and analyst event »

Investor and Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 07

    Dec

04:55
12/07/19
12/07
04:55
12/07/19
04:55
Conference/Events
JPMorgan enterprise software analyst to hold an analyst/industry conference call »

Software Analyst Murphy,…

RUHN

Ruhnn

$6.19

-0.2 (-3.13%)

04:55
12/07/19
12/07
04:55
12/07/19
04:55
Conference/Events
Ruhnn management to meet with Mizuho »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 08

    Dec

  • 09

    Dec

FITB

Fifth Third

$30.24

0.365 (1.22%)

, CSCO

Cisco

$43.83

0.29 (0.67%)

18:37
12/06/19
12/06
18:37
12/06/19
18:37
Hot Stocks
Fifth Third issues statement on temporary network outage »

Fifth Third Bank (FITB)…

FITB

Fifth Third

$30.24

0.365 (1.22%)

CSCO

Cisco

$43.83

0.29 (0.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 10

    Dec

  • 12

    Dec

  • 08

    Jan

  • 12

    Feb

STML

Stemline

$10.33

0.5 (5.09%)

, PFE

Pfizer

$38.29

0.26 (0.68%)

18:33
12/06/19
12/06
18:33
12/06/19
18:33
Hot Stocks
Stemline names Robert Francomano as Chief Commercial Officer »

Most recently, Francomano…

STML

Stemline

$10.33

0.5 (5.09%)

PFE

Pfizer

$38.29

0.26 (0.68%)

GSK

GlaxoSmithKline

$45.51

0.29 (0.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 09

    Dec

  • 11

    Dec

GOL

Gol Linhas

$17.39

1.07 (6.56%)

18:31
12/06/19
12/06
18:31
12/06/19
18:31
Hot Stocks
Gol Linhas announces preliminary traffic figures for November »

GOL's domestic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NAVB

Navidea

$0.97

0.07 (7.78%)

18:25
12/06/19
12/06
18:25
12/06/19
18:25
Syndicate
Navidea announces $1.9M private placement »

Navidea announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EFC

Ellington Financial

$18.22

0.09 (0.50%)

18:23
12/06/19
12/06
18:23
12/06/19
18:23
Hot Stocks
Ellington Financial reports estimated book value per share $18.51 on November 30 »

This estimate includes…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BOOT

Boot Barn

$41.93

0.81 (1.97%)

18:22
12/06/19
12/06
18:22
12/06/19
18:22
Hot Stocks
Boot Barn CEO: More than 80% of our business is in the store »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ERIC

Ericsson

$9.24

0.1 (1.09%)

18:18
12/06/19
12/06
18:18
12/06/19
18:18
Hot Stocks
Ericsson to pay over $1B to settle FCPA case »

Ericsson has agreed to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

GLD

SPDR Gold Shares

$137.59

-1.42 (-1.02%)

17:55
12/06/19
12/06
17:55
12/06/19
17:55
Hot Stocks
SPDR Gold Shares holdings fall to 886.23MT from 888.57MT »

This is the lowest level…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PICO

PICO Holdings

$10.81

0.31 (2.95%)

17:45
12/06/19
12/06
17:45
12/06/19
17:45
Hot Stocks
PICO Holdings sells long-term storage credits for $8.7M in Arizona »

PICO Holdings announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QHC

Quorum Health

$0.95

0.0522 (5.81%)

17:31
12/06/19
12/06
17:31
12/06/19
17:31
Hot Stocks
Quorum Health receives NYSE continued listing standard notice »

Quorum Health Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPRT

Support.com

$1.94

0.01 (0.52%)

17:30
12/06/19
12/06
17:30
12/06/19
17:30
Hot Stocks
Breaking Hot Stocks news story on Support.com »

Support.com trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BXRX

Baudax Bio

$6.69

0.34 (5.35%)

17:29
12/06/19
12/06
17:29
12/06/19
17:29
Syndicate
Breaking Syndicate news story on Baudax Bio »

Baudax Bio files $125M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Dec

LMT

Lockheed Martin

$387.10

1.175 (0.30%)

17:25
12/06/19
12/06
17:25
12/06/19
17:25
Hot Stocks
Lockheed Martin awarded $153.39M Navy contract modification »

Lockheed Martin was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENV

Envestnet

$71.72

1.27 (1.80%)

17:23
12/06/19
12/06
17:23
12/06/19
17:23
Syndicate
Breaking Syndicate news story on Envestnet »

Envestnet files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NOC

Northrop Grumman

$344.79

0.4 (0.12%)

17:20
12/06/19
12/06
17:20
12/06/19
17:20
Hot Stocks
Northrop Grumman awarded $189M Navy contract modification »

Northrop Grumman was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPRT

Support.com

$1.94

0.01 (0.52%)

17:03
12/06/19
12/06
17:03
12/06/19
17:03
Hot Stocks
Support.com announces special distribution of $1.00 per share »

The record date for the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPRT

Support.com

$1.94

0.01 (0.52%)

17:01
12/06/19
12/06
17:01
12/06/19
17:01
Hot Stocks
Breaking Hot Stocks news story on Support.com »

Support.com trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RZLT

Rezolute

$0.00

(0.00%)

17:00
12/06/19
12/06
17:00
12/06/19
17:00
Syndicate
Breaking Syndicate news story on Rezolute »

Rezolute files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,750.79

10.2 (0.59%)

16:58
12/06/19
12/06
16:58
12/06/19
16:58
Periodicals
U.S. mulls putting Amazon foreign sites on 'Notorious Markets' list, WSJ says »

The Trump administration…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MGTA

Magenta Therapeutics

$13.29

0.3 (2.31%)

16:55
12/06/19
12/06
16:55
12/06/19
16:55
Conference/Events
Magenta Therapeutics to hold an investor and analyst event »

Investor and Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 07

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.